With 95 percent of drugs failing clinical trials, it’s clear that a new approach is needed. Let’s not miss this chance to invest in a new kind of science.

With 95 percent of drugs failing clinical trials, it’s clear that a new approach is needed. Let’s not miss this chance to invest in a new kind of science.